Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
07/03/2023 | Talaris Therapeutics, Inc. | | Payment of Exercise | Common Stock | 11.8k | $3.08 | $36.3k | | 07/03/2023 |
09/10/2022 | Talaris Therapeutics, Inc. | | Grant | Common Stock | 80k | $0.00 | $0 | | 09/10/2022 |
07/29/2022 | Talaris Therapeutics, Inc. | | Purchase | Common Stock | 39.4k | $4.25 | $167.4k | | 07/29/2022 |
07/28/2022 | Talaris Therapeutics, Inc. | | Purchase | Common Stock | 3.1k | $4.25 | $13.1k | | 07/26/2022 |
07/26/2022 | Talaris Therapeutics, Inc. | | Purchase | Common Stock | 5.5k | $4.24 | $23.4k | | 07/26/2022 |
07/22/2022 | Talaris Therapeutics, Inc. | | Purchase | Common Stock | 9.4k | $3.75 | $35.4k | | 07/22/2022 |
02/01/2022 | Talaris Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 500k | $9.10 | $4.6M | | 02/01/2022 |
12/31/2021 | Talaris Therapeutics, Inc. | | Grant | Common Stock | 1.5k | $13.00 | $19.1k | | 02/01/2022 |
12/11/2020 | ESSA Pharma Inc. | EPIX | Grant | Stock Option (Right to Buy) | 16.5k | $7.00 | $115.5k | | 12/11/2020 |
12/11/2020 | ESSA Pharma Inc. | EPIX | Grant | Stock Option (Right to Buy) | 16.5k | $7.00 | $115.5k | | 12/11/2020 |
01/31/2019 | VBI Vaccines Inc/BC | VBIV | Grant | Option (Right to Buy Common Shares) | 200k | $1.67 | $334k | | 01/31/2019 |
06/25/2018 | AVROBIO, Inc. | AVRO | Conversion | Common Stock | 2.3M | $0.00 | $0 | See Footnote | 06/25/2018 |
06/25/2018 | AVROBIO, Inc. | AVRO | Conversion | Common Stock | 678.9k | $0.00 | $0 | See Footnote | 06/25/2018 |
06/25/2018 | AVROBIO, Inc. | AVRO | Conversion | Series A Preferred Stock | 9.4M | $0.00 | $0 | See footnote | 06/25/2018 |
06/25/2018 | AVROBIO, Inc. | AVRO | Conversion | Series B Preferred Stock | 2.8M | $0.00 | $0 | See footnote | 06/25/2018 |
06/14/2018 | VBI Vaccines Inc/BC | VBIV | Exercise | Restricted Stock Units (RSUs) | 12.5k | $0.00 | $0 | | 06/14/2018 |
01/23/2018 | VBI Vaccines Inc/BC | VBIV | Grant | Option (Right to Buy Common Shares) | 75k | $4.19 | $314.2k | | 01/23/2018 |
03/31/2017 | VBI Vaccines Inc/BC | VBIV | Grant | Option (Right to Buy Common Shares) | 12.5k | $3.79 | $47.4k | | 03/31/2017 |